ARK Genomic (Switzerland) Technical Analysis
| ARKG Etf | 4.21 0.07 1.64% |
As of the 3rd of March, ARK Genomic shows the Risk Adjusted Performance of 0.0205, mean deviation of 1.81, and Semi Deviation of 1.99. Our technical analysis interface gives you tools to check helpful technical drivers of ARK Genomic, as well as the relationship between them. Please confirm ARK Genomic downside deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if ARK Genomic is priced favorably, providing market reflects its regular price of 4.21 per share.
ARK Genomic Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as ARK, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ARKARK |
ARK Genomic 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ARK Genomic's etf what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ARK Genomic.
| 12/03/2025 |
| 03/03/2026 |
If you would invest 0.00 in ARK Genomic on December 3, 2025 and sell it all today you would earn a total of 0.00 from holding ARK Genomic or generate 0.0% return on investment in ARK Genomic over 90 days. ARK Genomic is related to or competes with IShares Gold, IShares MSCI, Lyxor MSCI, IShares Global, IShares MSCI, Lyxor MSCI, and IShares MSCI. ARK Genomic is entity of Switzerland. It is traded as Etf on SW exchange. More
ARK Genomic Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ARK Genomic's etf current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ARK Genomic upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.15 | |||
| Information Ratio | (0.0007) | |||
| Maximum Drawdown | 14.62 | |||
| Value At Risk | (2.76) | |||
| Potential Upside | 4.19 |
ARK Genomic Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ARK Genomic's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ARK Genomic's standard deviation. In reality, there are many statistical measures that can use ARK Genomic historical prices to predict the future ARK Genomic's volatility.| Risk Adjusted Performance | 0.0205 | |||
| Jensen Alpha | 0.0106 | |||
| Total Risk Alpha | (0.09) | |||
| Sortino Ratio | (0.0008) | |||
| Treynor Ratio | 0.0527 |
ARK Genomic March 3, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0205 | |||
| Market Risk Adjusted Performance | 0.0627 | |||
| Mean Deviation | 1.81 | |||
| Semi Deviation | 1.99 | |||
| Downside Deviation | 2.15 | |||
| Coefficient Of Variation | 5584.27 | |||
| Standard Deviation | 2.52 | |||
| Variance | 6.36 | |||
| Information Ratio | (0.0007) | |||
| Jensen Alpha | 0.0106 | |||
| Total Risk Alpha | (0.09) | |||
| Sortino Ratio | (0.0008) | |||
| Treynor Ratio | 0.0527 | |||
| Maximum Drawdown | 14.62 | |||
| Value At Risk | (2.76) | |||
| Potential Upside | 4.19 | |||
| Downside Variance | 4.61 | |||
| Semi Variance | 3.97 | |||
| Expected Short fall | (2.34) | |||
| Skewness | 0.8178 | |||
| Kurtosis | 2.28 |
ARK Genomic Backtested Returns
ARK Genomic secures Sharpe Ratio (or Efficiency) of -0.0266, which signifies that the etf had a -0.0266 % return per unit of return volatility over the last 3 months. ARK Genomic exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm ARK Genomic's Risk Adjusted Performance of 0.0205, semi deviation of 1.99, and Mean Deviation of 1.81 to double-check the risk estimate we provide. The etf shows a Beta (market volatility) of 0.67, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, ARK Genomic's returns are expected to increase less than the market. However, during the bear market, the loss of holding ARK Genomic is expected to be smaller as well.
Auto-correlation | 0.11 |
Insignificant predictability
ARK Genomic has insignificant predictability. Overlapping area represents the amount of predictability between ARK Genomic time series from 3rd of December 2025 to 17th of January 2026 and 17th of January 2026 to 3rd of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ARK Genomic price movement. The serial correlation of 0.11 indicates that less than 11.0% of current ARK Genomic price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.11 | |
| Spearman Rank Test | -0.22 | |
| Residual Average | 0.0 | |
| Price Variance | 0.08 |
ARK Genomic technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.
ARK Genomic Technical Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Normalized Average True Range is used to analyze tradable apportunities for ARK Genomic across different markets.
About ARK Genomic Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of ARK Genomic on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of ARK Genomic based on its technical analysis. In general, a bottom-up approach, as applied to this etf, focuses on ARK Genomic price pattern first instead of the macroeconomic environment surrounding ARK Genomic. By analyzing ARK Genomic's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of ARK Genomic's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to ARK Genomic specific price patterns or momentum indicators. Please read more on our technical analysis page.
ARK Genomic March 3, 2026 Technical Indicators
Most technical analysis of ARK help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for ARK from various momentum indicators to cycle indicators. When you analyze ARK charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0205 | |||
| Market Risk Adjusted Performance | 0.0627 | |||
| Mean Deviation | 1.81 | |||
| Semi Deviation | 1.99 | |||
| Downside Deviation | 2.15 | |||
| Coefficient Of Variation | 5584.27 | |||
| Standard Deviation | 2.52 | |||
| Variance | 6.36 | |||
| Information Ratio | (0.0007) | |||
| Jensen Alpha | 0.0106 | |||
| Total Risk Alpha | (0.09) | |||
| Sortino Ratio | (0.0008) | |||
| Treynor Ratio | 0.0527 | |||
| Maximum Drawdown | 14.62 | |||
| Value At Risk | (2.76) | |||
| Potential Upside | 4.19 | |||
| Downside Variance | 4.61 | |||
| Semi Variance | 3.97 | |||
| Expected Short fall | (2.34) | |||
| Skewness | 0.8178 | |||
| Kurtosis | 2.28 |
ARK Genomic March 3, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as ARK stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 136.38 | ||
| Daily Balance Of Power | (0.70) | ||
| Rate Of Daily Change | 0.98 | ||
| Day Median Price | 4.26 | ||
| Day Typical Price | 4.24 | ||
| Price Action Indicator | (0.08) |
Other Information on Investing in ARK Etf
ARK Genomic financial ratios help investors to determine whether ARK Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ARK with respect to the benefits of owning ARK Genomic security.